Clinical Trials Directory

Trials / Completed

CompletedNCT01123759

Healthful Seafood Consumption for Sensitive Populations

Consuming Fish to Reduce Mercury Intake While Optimizing Omega-3 Fatty Acid Status

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
71 (actual)
Sponsor
Purdue University · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

Fish can provide pregnant women with omega-3 fatty acids for fetal brain development but some fish contains high levels of mercury which is detrimental to fetal brain development. The hypothesis is that women who have previously consumed high mercury fish can reduce the mercury level in their bodies and improve their omega-3 levels in three months by eating fish that is high in omega-3 fatty acids and low in mercury.

Detailed description

Exposure to methylmercury, a developmental toxicant found primarily in fish. Fish is nutritionally important for providing long chain omega-3 fatty acids that are important for perinatal health. Since maternal transfer of mercury and omega-3 fatty acids are the primary routes for fetal (placental transfer) or infant (maternal milk) exposure, there is a critical need to develop specific advice for childbearing-aged women based upon the 2004 Dietary Guidelines Advisory Committee's recommended intake i.e., consume 8 ounces of fish per week. This clinical trial investigates whether weekly consumption of selected fish species for 12 weeks can improve plasma concentrations of the omega-3 fatty acids (eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)) while reducing hair or blood mercury concentrations.

Conditions

Interventions

TypeNameDescription
OTHERFeeding low mercury fishSubjects fed 6 oz of either tilapia (low omega-3 fish) or salmon (high omega-3 fish) for 3 months. Both fish are low in mercury

Timeline

Start date
2008-01-01
Primary completion
2009-12-01
Completion
2009-12-01
First posted
2010-05-14
Last updated
2010-05-14

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01123759. Inclusion in this directory is not an endorsement.